The global Melatonin Receptor Agonists market size was valued at USD 238.7 million in 2022 and is forecast to a readjusted size of USD 452.6 million by 2029 with a CAGR of 9.6% during review period.
The market for melatonin receptor agonists has witnessed growth in recent years due to the increasing recognition of the importance of sleep health and the rising prevalence of sleep disorders worldwide. Factors contributing to the market growth include lifestyle changes, stress-related sleep disturbances, shift work, and the growing elderly population, as sleep disorders tend to be more common in older adults.
Melatonin receptor agonists, also known as melatonin agonists or melatonergic drugs, are a class of medications that bind and activate melatonin receptors in the brain. These receptors play a crucial role in regulating the sleep-wake cycle and circadian rhythms.
This report is a detailed and comprehensive analysis for global Melatonin Receptor Agonists market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Melatonin Receptor Agonists market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Melatonin Receptor Agonists market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Melatonin Receptor Agonists market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Melatonin Receptor Agonists market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Melatonin Receptor Agonists
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Melatonin Receptor Agonists market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Takeda Pharmaceutical
Vanda Pharmaceuticals
Pfizer
Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Xiu Zheng
Church & Dwight
BY-HEALTH
Solgar
Biotics Research
Now Food
Ramelteon
Tasimelteon
Agomelatine
Other
Hospital
Clinic
Other
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Melatonin Receptor Agonists product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Melatonin Receptor Agonists, with price, sales, revenue and global market share of Melatonin Receptor Agonists from 2018 to 2023.
Chapter 3, the Melatonin Receptor Agonists competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Melatonin Receptor Agonists breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Melatonin Receptor Agonists market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Melatonin Receptor Agonists.
Chapter 14 and 15, to describe Melatonin Receptor Agonists sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Melatonin Receptor Agonists
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Melatonin Receptor Agonists Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Ramelteon
1.3.3 Tasimelteon
1.3.4 Agomelatine
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Melatonin Receptor Agonists Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Melatonin Receptor Agonists Market Size & Forecast
1.5.1 Global Melatonin Receptor Agonists Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Melatonin Receptor Agonists Sales Quantity (2018-2029)
1.5.3 Global Melatonin Receptor Agonists Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Takeda Pharmaceutical
2.1.1 Takeda Pharmaceutical Details
2.1.2 Takeda Pharmaceutical Major Business
2.1.3 Takeda Pharmaceutical Melatonin Receptor Agonists Product and Services
2.1.4 Takeda Pharmaceutical Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Takeda Pharmaceutical Recent Developments/Updates
2.2 Vanda Pharmaceuticals
2.2.1 Vanda Pharmaceuticals Details
2.2.2 Vanda Pharmaceuticals Major Business
2.2.3 Vanda Pharmaceuticals Melatonin Receptor Agonists Product and Services
2.2.4 Vanda Pharmaceuticals Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Vanda Pharmaceuticals Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Melatonin Receptor Agonists Product and Services
2.3.4 Pfizer Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments/Updates
2.4 Natrol
2.4.1 Natrol Details
2.4.2 Natrol Major Business
2.4.3 Natrol Melatonin Receptor Agonists Product and Services
2.4.4 Natrol Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Natrol Recent Developments/Updates
2.5 Pharmavite
2.5.1 Pharmavite Details
2.5.2 Pharmavite Major Business
2.5.3 Pharmavite Melatonin Receptor Agonists Product and Services
2.5.4 Pharmavite Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Pharmavite Recent Developments/Updates
2.6 Nature's Bounty
2.6.1 Nature's Bounty Details
2.6.2 Nature's Bounty Major Business
2.6.3 Nature's Bounty Melatonin Receptor Agonists Product and Services
2.6.4 Nature's Bounty Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Nature's Bounty Recent Developments/Updates
2.7 Jameison
2.7.1 Jameison Details
2.7.2 Jameison Major Business
2.7.3 Jameison Melatonin Receptor Agonists Product and Services
2.7.4 Jameison Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Jameison Recent Developments/Updates
2.8 Rexall Sundown
2.8.1 Rexall Sundown Details
2.8.2 Rexall Sundown Major Business
2.8.3 Rexall Sundown Melatonin Receptor Agonists Product and Services
2.8.4 Rexall Sundown Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Rexall Sundown Recent Developments/Updates
2.9 GNC
2.9.1 GNC Details
2.9.2 GNC Major Business
2.9.3 GNC Melatonin Receptor Agonists Product and Services
2.9.4 GNC Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GNC Recent Developments/Updates
2.10 Xiu Zheng
2.10.1 Xiu Zheng Details
2.10.2 Xiu Zheng Major Business
2.10.3 Xiu Zheng Melatonin Receptor Agonists Product and Services
2.10.4 Xiu Zheng Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Xiu Zheng Recent Developments/Updates
2.11 Church & Dwight
2.11.1 Church & Dwight Details
2.11.2 Church & Dwight Major Business
2.11.3 Church & Dwight Melatonin Receptor Agonists Product and Services
2.11.4 Church & Dwight Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Church & Dwight Recent Developments/Updates
2.12 BY-HEALTH
2.12.1 BY-HEALTH Details
2.12.2 BY-HEALTH Major Business
2.12.3 BY-HEALTH Melatonin Receptor Agonists Product and Services
2.12.4 BY-HEALTH Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 BY-HEALTH Recent Developments/Updates
2.13 Solgar
2.13.1 Solgar Details
2.13.2 Solgar Major Business
2.13.3 Solgar Melatonin Receptor Agonists Product and Services
2.13.4 Solgar Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Solgar Recent Developments/Updates
2.14 Biotics Research
2.14.1 Biotics Research Details
2.14.2 Biotics Research Major Business
2.14.3 Biotics Research Melatonin Receptor Agonists Product and Services
2.14.4 Biotics Research Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Biotics Research Recent Developments/Updates
2.15 Now Food
2.15.1 Now Food Details
2.15.2 Now Food Major Business
2.15.3 Now Food Melatonin Receptor Agonists Product and Services
2.15.4 Now Food Melatonin Receptor Agonists Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Now Food Recent Developments/Updates
3 Competitive Environment: Melatonin Receptor Agonists by Manufacturer
3.1 Global Melatonin Receptor Agonists Sales Quantity by Manufacturer (2018-2023)
3.2 Global Melatonin Receptor Agonists Revenue by Manufacturer (2018-2023)
3.3 Global Melatonin Receptor Agonists Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Melatonin Receptor Agonists by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Melatonin Receptor Agonists Manufacturer Market Share in 2022
3.4.2 Top 6 Melatonin Receptor Agonists Manufacturer Market Share in 2022
3.5 Melatonin Receptor Agonists Market: Overall Company Footprint Analysis
3.5.1 Melatonin Receptor Agonists Market: Region Footprint
3.5.2 Melatonin Receptor Agonists Market: Company Product Type Footprint
3.5.3 Melatonin Receptor Agonists Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Melatonin Receptor Agonists Market Size by Region
4.1.1 Global Melatonin Receptor Agonists Sales Quantity by Region (2018-2029)
4.1.2 Global Melatonin Receptor Agonists Consumption Value by Region (2018-2029)
4.1.3 Global Melatonin Receptor Agonists Average Price by Region (2018-2029)
4.2 North America Melatonin Receptor Agonists Consumption Value (2018-2029)
4.3 Europe Melatonin Receptor Agonists Consumption Value (2018-2029)
4.4 Asia-Pacific Melatonin Receptor Agonists Consumption Value (2018-2029)
4.5 South America Melatonin Receptor Agonists Consumption Value (2018-2029)
4.6 Middle East and Africa Melatonin Receptor Agonists Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Melatonin Receptor Agonists Sales Quantity by Type (2018-2029)
5.2 Global Melatonin Receptor Agonists Consumption Value by Type (2018-2029)
5.3 Global Melatonin Receptor Agonists Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Melatonin Receptor Agonists Sales Quantity by Application (2018-2029)
6.2 Global Melatonin Receptor Agonists Consumption Value by Application (2018-2029)
6.3 Global Melatonin Receptor Agonists Average Price by Application (2018-2029)
7 North America
7.1 North America Melatonin Receptor Agonists Sales Quantity by Type (2018-2029)
7.2 North America Melatonin Receptor Agonists Sales Quantity by Application (2018-2029)
7.3 North America Melatonin Receptor Agonists Market Size by Country
7.3.1 North America Melatonin Receptor Agonists Sales Quantity by Country (2018-2029)
7.3.2 North America Melatonin Receptor Agonists Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Melatonin Receptor Agonists Sales Quantity by Type (2018-2029)
8.2 Europe Melatonin Receptor Agonists Sales Quantity by Application (2018-2029)
8.3 Europe Melatonin Receptor Agonists Market Size by Country
8.3.1 Europe Melatonin Receptor Agonists Sales Quantity by Country (2018-2029)
8.3.2 Europe Melatonin Receptor Agonists Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Melatonin Receptor Agonists Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Melatonin Receptor Agonists Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Melatonin Receptor Agonists Market Size by Region
9.3.1 Asia-Pacific Melatonin Receptor Agonists Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Melatonin Receptor Agonists Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Melatonin Receptor Agonists Sales Quantity by Type (2018-2029)
10.2 South America Melatonin Receptor Agonists Sales Quantity by Application (2018-2029)
10.3 South America Melatonin Receptor Agonists Market Size by Country
10.3.1 South America Melatonin Receptor Agonists Sales Quantity by Country (2018-2029)
10.3.2 South America Melatonin Receptor Agonists Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Melatonin Receptor Agonists Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Melatonin Receptor Agonists Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Melatonin Receptor Agonists Market Size by Country
11.3.1 Middle East & Africa Melatonin Receptor Agonists Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Melatonin Receptor Agonists Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Melatonin Receptor Agonists Market Drivers
12.2 Melatonin Receptor Agonists Market Restraints
12.3 Melatonin Receptor Agonists Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Melatonin Receptor Agonists and Key Manufacturers
13.2 Manufacturing Costs Percentage of Melatonin Receptor Agonists
13.3 Melatonin Receptor Agonists Production Process
13.4 Melatonin Receptor Agonists Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Melatonin Receptor Agonists Typical Distributors
14.3 Melatonin Receptor Agonists Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Melatonin Receptor Agonists Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Melatonin Receptor Agonists Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Pharmaceutical Major Business
Table 5. Takeda Pharmaceutical Melatonin Receptor Agonists Product and Services
Table 6. Takeda Pharmaceutical Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Takeda Pharmaceutical Recent Developments/Updates
Table 8. Vanda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Vanda Pharmaceuticals Major Business
Table 10. Vanda Pharmaceuticals Melatonin Receptor Agonists Product and Services
Table 11. Vanda Pharmaceuticals Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Vanda Pharmaceuticals Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Melatonin Receptor Agonists Product and Services
Table 16. Pfizer Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Pfizer Recent Developments/Updates
Table 18. Natrol Basic Information, Manufacturing Base and Competitors
Table 19. Natrol Major Business
Table 20. Natrol Melatonin Receptor Agonists Product and Services
Table 21. Natrol Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Natrol Recent Developments/Updates
Table 23. Pharmavite Basic Information, Manufacturing Base and Competitors
Table 24. Pharmavite Major Business
Table 25. Pharmavite Melatonin Receptor Agonists Product and Services
Table 26. Pharmavite Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Pharmavite Recent Developments/Updates
Table 28. Nature's Bounty Basic Information, Manufacturing Base and Competitors
Table 29. Nature's Bounty Major Business
Table 30. Nature's Bounty Melatonin Receptor Agonists Product and Services
Table 31. Nature's Bounty Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Nature's Bounty Recent Developments/Updates
Table 33. Jameison Basic Information, Manufacturing Base and Competitors
Table 34. Jameison Major Business
Table 35. Jameison Melatonin Receptor Agonists Product and Services
Table 36. Jameison Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Jameison Recent Developments/Updates
Table 38. Rexall Sundown Basic Information, Manufacturing Base and Competitors
Table 39. Rexall Sundown Major Business
Table 40. Rexall Sundown Melatonin Receptor Agonists Product and Services
Table 41. Rexall Sundown Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Rexall Sundown Recent Developments/Updates
Table 43. GNC Basic Information, Manufacturing Base and Competitors
Table 44. GNC Major Business
Table 45. GNC Melatonin Receptor Agonists Product and Services
Table 46. GNC Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. GNC Recent Developments/Updates
Table 48. Xiu Zheng Basic Information, Manufacturing Base and Competitors
Table 49. Xiu Zheng Major Business
Table 50. Xiu Zheng Melatonin Receptor Agonists Product and Services
Table 51. Xiu Zheng Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Xiu Zheng Recent Developments/Updates
Table 53. Church & Dwight Basic Information, Manufacturing Base and Competitors
Table 54. Church & Dwight Major Business
Table 55. Church & Dwight Melatonin Receptor Agonists Product and Services
Table 56. Church & Dwight Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Church & Dwight Recent Developments/Updates
Table 58. BY-HEALTH Basic Information, Manufacturing Base and Competitors
Table 59. BY-HEALTH Major Business
Table 60. BY-HEALTH Melatonin Receptor Agonists Product and Services
Table 61. BY-HEALTH Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. BY-HEALTH Recent Developments/Updates
Table 63. Solgar Basic Information, Manufacturing Base and Competitors
Table 64. Solgar Major Business
Table 65. Solgar Melatonin Receptor Agonists Product and Services
Table 66. Solgar Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Solgar Recent Developments/Updates
Table 68. Biotics Research Basic Information, Manufacturing Base and Competitors
Table 69. Biotics Research Major Business
Table 70. Biotics Research Melatonin Receptor Agonists Product and Services
Table 71. Biotics Research Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Biotics Research Recent Developments/Updates
Table 73. Now Food Basic Information, Manufacturing Base and Competitors
Table 74. Now Food Major Business
Table 75. Now Food Melatonin Receptor Agonists Product and Services
Table 76. Now Food Melatonin Receptor Agonists Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Now Food Recent Developments/Updates
Table 78. Global Melatonin Receptor Agonists Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Melatonin Receptor Agonists Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Melatonin Receptor Agonists Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Melatonin Receptor Agonists, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Melatonin Receptor Agonists Production Site of Key Manufacturer
Table 83. Melatonin Receptor Agonists Market: Company Product Type Footprint
Table 84. Melatonin Receptor Agonists Market: Company Product Application Footprint
Table 85. Melatonin Receptor Agonists New Market Entrants and Barriers to Market Entry
Table 86. Melatonin Receptor Agonists Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Melatonin Receptor Agonists Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Melatonin Receptor Agonists Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Melatonin Receptor Agonists Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Melatonin Receptor Agonists Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Melatonin Receptor Agonists Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Melatonin Receptor Agonists Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Melatonin Receptor Agonists Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Melatonin Receptor Agonists Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Melatonin Receptor Agonists Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Melatonin Receptor Agonists Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Melatonin Receptor Agonists Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Melatonin Receptor Agonists Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Melatonin Receptor Agonists Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Melatonin Receptor Agonists Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Melatonin Receptor Agonists Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Melatonin Receptor Agonists Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Melatonin Receptor Agonists Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Melatonin Receptor Agonists Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Melatonin Receptor Agonists Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Melatonin Receptor Agonists Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Melatonin Receptor Agonists Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Melatonin Receptor Agonists Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Melatonin Receptor Agonists Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Melatonin Receptor Agonists Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Melatonin Receptor Agonists Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Melatonin Receptor Agonists Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Melatonin Receptor Agonists Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Melatonin Receptor Agonists Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Melatonin Receptor Agonists Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Melatonin Receptor Agonists Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Melatonin Receptor Agonists Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Melatonin Receptor Agonists Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Melatonin Receptor Agonists Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Melatonin Receptor Agonists Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Melatonin Receptor Agonists Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Melatonin Receptor Agonists Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Melatonin Receptor Agonists Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Melatonin Receptor Agonists Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Melatonin Receptor Agonists Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Melatonin Receptor Agonists Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Melatonin Receptor Agonists Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Melatonin Receptor Agonists Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Melatonin Receptor Agonists Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Melatonin Receptor Agonists Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Melatonin Receptor Agonists Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Melatonin Receptor Agonists Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Melatonin Receptor Agonists Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Melatonin Receptor Agonists Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Melatonin Receptor Agonists Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Melatonin Receptor Agonists Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Melatonin Receptor Agonists Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Melatonin Receptor Agonists Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Melatonin Receptor Agonists Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Melatonin Receptor Agonists Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Melatonin Receptor Agonists Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Melatonin Receptor Agonists Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Melatonin Receptor Agonists Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Melatonin Receptor Agonists Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Melatonin Receptor Agonists Raw Material
Table 146. Key Manufacturers of Melatonin Receptor Agonists Raw Materials
Table 147. Melatonin Receptor Agonists Typical Distributors
Table 148. Melatonin Receptor Agonists Typical Customers
List of Figures
Figure 1. Melatonin Receptor Agonists Picture
Figure 2. Global Melatonin Receptor Agonists Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Melatonin Receptor Agonists Consumption Value Market Share by Type in 2022
Figure 4. Ramelteon Examples
Figure 5. Tasimelteon Examples
Figure 6. Agomelatine Examples
Figure 7. Other Examples
Figure 8. Global Melatonin Receptor Agonists Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Melatonin Receptor Agonists Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Other Examples
Figure 13. Global Melatonin Receptor Agonists Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Melatonin Receptor Agonists Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Melatonin Receptor Agonists Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Melatonin Receptor Agonists Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Melatonin Receptor Agonists Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Melatonin Receptor Agonists Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Melatonin Receptor Agonists by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Melatonin Receptor Agonists Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Melatonin Receptor Agonists Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Melatonin Receptor Agonists Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Melatonin Receptor Agonists Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Melatonin Receptor Agonists Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Melatonin Receptor Agonists Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Melatonin Receptor Agonists Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Melatonin Receptor Agonists Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Melatonin Receptor Agonists Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Melatonin Receptor Agonists Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Melatonin Receptor Agonists Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Melatonin Receptor Agonists Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Melatonin Receptor Agonists Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Melatonin Receptor Agonists Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Melatonin Receptor Agonists Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Melatonin Receptor Agonists Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Melatonin Receptor Agonists Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Melatonin Receptor Agonists Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Melatonin Receptor Agonists Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Melatonin Receptor Agonists Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Melatonin Receptor Agonists Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Melatonin Receptor Agonists Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Melatonin Receptor Agonists Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Melatonin Receptor Agonists Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Melatonin Receptor Agonists Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Melatonin Receptor Agonists Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Melatonin Receptor Agonists Consumption Value Market Share by Region (2018-2029)
Figure 55. China Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Melatonin Receptor Agonists Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Melatonin Receptor Agonists Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Melatonin Receptor Agonists Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Melatonin Receptor Agonists Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Melatonin Receptor Agonists Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Melatonin Receptor Agonists Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Melatonin Receptor Agonists Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Melatonin Receptor Agonists Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Melatonin Receptor Agonists Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Melatonin Receptor Agonists Market Drivers
Figure 76. Melatonin Receptor Agonists Market Restraints
Figure 77. Melatonin Receptor Agonists Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Melatonin Receptor Agonists in 2022
Figure 80. Manufacturing Process Analysis of Melatonin Receptor Agonists
Figure 81. Melatonin Receptor Agonists Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
